2025
32. Liu, C.; Huang, X.; Chen, K.-S.; Xiong, S.; Yaremenko, A.
V.; Zhen, X.; You, X.; Rossignoli, F.; Tang, Y.; Koo, S.; Chen, W.; Kong, N.; Xie, T.; Shah, K.;
Tao, W. Systemic reprogramming of tumour immunity via IL-10-mRNA nanoparticles.
Nature Nanotechnology 2025, 20, (10), 1526-1538.
31. Huang, X.; Liu, C.; Sharma, S. N.; You, X.; Chen, S.; Li,
Y.; Liu, H.-J.; Liu, B.; Saiding, Q.; Chen, W.; Lee, Y.; Kong, N.; Abdi, R.; Tao, W. Oral
delivery of liquid mRNA therapeutics by an engineered capsule for treatment of preclinical
intestinal disease. Science Translational Medicine 2025, 17, (807),
eadu1493.
Cover
paper
Cover
story of American Scientist, 2026, 114(1): 32
30. Huang, X.; Li, Y.; Torre, M.; Shao, R.; Zhang, W.; Wang,
Z.; Kohane, D. S.; Weldon, C. B. Enhanced control of liposomal drug release by drug–aptamer
complexes. Advanced Materials 2025, 37, (40), 2503872.
Cover
paper
2023
29. Xu, L.; Deng, H.; Wu, L.; Wang, D.; Shi, L.; Qian, Q.; Huang,
X.; Zhu, L.; Gao, X.; Yang, J.; Su, Y.; Feng, J.; Zhu, X. Supramolecular Cyclic
Dinucleotide Nanoparticles for STING-Mediated Cancer Immunotherapy. ACS
Nano 2023, 17, (11), 10090-10103.
28. Tang, Z.; You, X.; Xiao, Y.; Chen, W.; Li, Y.; Huang, X.;
Liu, H.; Xiao, F.; Liu, C.; Koo, S.; Kong, N.; Tao, W. Inhaled mRNA nanoparticles dual-targeting
cancer cells and macrophages in the lung for effective transfection. Proceedings of
the National Academy of Sciences 2023, 120, (44), e2304966120.
27. Ouyang, J.; Zhang, Z.; Deng, B.; Liu, J.; Wang, L.; Liu, H.; Koo, S.; Chen,
S.; Li, Y.; Yaremenko, A. V.; Huang, X.; Chen, W.; Lee, Y.; Tao, W. Oral drug
delivery platforms for biomedical applications. Materials Today 2023,
62, 296-326.
26. Liu, H.-J.; Chen, W.; Wu, G.; Zhou, J.; Liu, C.; Tang, Z.; Huang,
X.; Gao, J.; Xiao, Y.; Kong, N.; Joshi, N.; Cao, Y.; Abdi, R.; Tao, W.
Glutathione-Scavenging Nanoparticle-Mediated PROTACs Delivery for Targeted Protein Degradation
and Amplified Antitumor Effects. Advanced Science 2023, 10, (16),
2207439.
25. Liu, C.; Shi, Q.; Huang, X.; Koo, S.; Kong, N.; Tao, W.
mRNA-based cancer therapeutics. Nature Reviews Cancer 2023, 23, (8),
526-543.
24. Li, Y.; Chen, W.; Kang, Y.; Zhen, X.; Zhou, Z.; Liu, C.; Chen, S.;
Huang, X.; Liu, H.-J.; Koo, S.; Kong, N.; Ji, X.; Xie, T.; Tao, W.
Nanosensitizer-mediated augmentation of sonodynamic therapy efficacy and antitumor immunity.
Nature Communications 2023, 14, (1), 6973.
23. Chen, W.; Li, Y.; Liu, C.; Kang, Y.; Qin, D.; Chen, S.; Zhou, J.; Liu,
H.-J.; Ferdows, B. E.; Patel, D. N.; Huang, X.; Koo, S.; Kong, N.; Ji, X.; Cao,
Y.; Tao, W.; Xie, T. In situ Engineering of Tumor-Associated Macrophages via a
Nanodrug-Delivering-Drug (β-Elemene@Stanene) Strategy for Enhanced Cancer Chemo-Immunotherapy.
Angewandte Chemie International Edition 2023, 62, (41), e202308413.
22. Chen, S.; Huang, X.#; Xue, Y.; Álvarez-Benedicto, E.; Shi,
Y.; Chen, W.; Koo, S.; Siegwart, D. J.; Dong, Y.; Tao, W. Nanotechnology-based mRNA vaccines.
Nature Reviews Methods Primers 2023, 3, (1), 63. (#Co-first
author)
2022
21. Zou, Y.; Sun, X.; Yang, Q.; Zheng, M.; Shimoni, O.; Ruan, W.; Wang, Y.;
Zhang, D.; Yin, J.; Huang, X.; Tao, W.; Park, J. B.; Liang, X.-J.; Leong, K.
W.; Shi, B. Blood-brain barrier–penetrating single CRISPR-Cas9 nanocapsules for effective and
safe glioblastoma gene therapy. Science Advances 2022, 8, (16),
eabm8011.
20. Xiao, Y.; Tang, Z.; Huang, X.#; Chen, W.; Zhou, J.; Liu,
H.; Liu, C.; Kong, N.; Tao, W. Emerging mRNA technologies: delivery strategies and biomedical
applications. Chemical Society Reviews 2022, 51, (10), 3828-3845.
(#Co-first author)
Cover
paper
19. Huang, X.; Liu, C.; Kong, N.; Xiao, Y.; Yurdagul, A.;
Tabas, I.; Tao, W. Synthesis of siRNA nanoparticles to silence plaque-destabilizing gene in
atherosclerotic lesional macrophages. Nature Protocols 2022, 17, (3),
748-780.
18. Huang, X.; Kong, N.; Zhang, X.; Cao, Y.; Langer, R.; Tao,
W. The landscape of mRNA nanomedicine. Nat. Med. 2022, 28, (11),
2273-2287.
Featured
article by Nature Medicine
Highlighted
in the "Nobel Prize in Physiology or Medicine 2023" Collection by Nature
17. Huang, X.; Kon, E.; Han, X.; Zhang, X.; Kong, N.;
Mitchell, M. J.; Peer, D.; Tao, W. Nanotechnology-based strategies against SARS-CoV-2 variants.
Nature Nanotechnology 2022, 17, (10), 1027-1037.
16. Ferdows, B. E.; Patel, D. N.; Chen, W.; Huang, X.; Kong,
N.; Tao, W. RNA cancer nanomedicine: nanotechnology-mediated RNA therapy.
Nanoscale 2022, 14, (12), 4448-4455.
2021
15. Zhang, X.; Koo, S.; Kim, J. H.; Huang, X.#; Kong, N.;
Zhang, L.; Zhou, J.; Xue, J.; Harris, M. B.; Tao, W.; Kim, J. S. Nanoscale materials-based
platforms for the treatment of bone-related diseases. Matter 2021, 4,
(9), 2727-2764. (#Co-first author)
14. Xiao, Y.; Tang, Z.; Huang, X.; Joseph, J.; Chen, W.; Liu,
C.; Zhou, J.; Kong, N.; Joshi, N.; Du, J.; Tao, W. Glucose-responsive oral insulin delivery
platform for one treatment a day in diabetes. Matter 2021, 4, (10),
3269-3285.
13. Tang, Z.; Xiao, Y.; Kong, N.; Liu, C.; Chen, W.; Huang,
X.; Xu, D.; Ouyang, J.; Feng, C.; Wang, C.; Wang, J.; Zhang, H.; Tao, W. Nano-bio
interfaces effect of two-dimensional nanomaterials and their applications in cancer
immunotherapy. Acta Pharmaceutica Sinica B 2021, 11, (11), 3447-3464.
12. Liu, C.; Sun, S.; Feng, Q.; Wu, G.; Wu, Y.; Kong, N.; Yu, Z.; Yao, J.;
Zhang, X.; Chen, W.; Tang, Z.; Xiao, Y.; Huang, X.; Lv, A.; Yao, C.; Cheng, H.;
Wu, A.; Xie, T.; Tao, W. Arsenene Nanodots with Selective Killing Effects and their Low-Dose
Combination with ß-Elemene for Cancer Therapy. Advanced Materials
2021, 33, (37), 2102054.
11. Li, S.; Wang, L.; Gu, Y.; Lin, L.; Zhang, M.; Jin, M.; Mao, C.; Zhou, J.;
Zhang, W.; Huang, X.; Corbo, C.; Tao, W.; Lu, E.; Liu, J. Biomimetic
immunomodulation by crosstalk with nanoparticulate regulatory T cells.
Matter 2021, 4, (11), 3621-3645.
10. Huang, X.; Wu, G.; Liu, C.; Hua, X.; Tang, Z.; Xiao, Y.;
Chen, W.; Zhou, J.; Kong, N.; Huang, P.; Shi, J.; Tao, W. Intercalation-Driven Formation of
siRNA Nanogels for Cancer Therapy. Nano Letters 2021, 21, (22),
9706-9714.
9. Huang, X.; Blum, N. T.; Lin, J.; Shi, J.; Zhang, C.; Huang,
P. Chemotherapeutic drug–DNA hybrid nanostructures for anti-tumor therapy. Materials
Horizons 2021, 8, (1), 78-101.
2020
8. Huang, X.; Zheng, R.; Ding, F.; Yang, J.; Xie, M.; Liu, X.;
Li, J.; Feng, J.; Zhu, X.; Zhang, C. Efficient Delivery of mRNA Using Crosslinked Nucleic Acid
Nanogel as a Carrier. ACS Materials Letters 2020, 2, 1509-1515.
7. Ding, F.; Gao, X.; Huang, X.; Ge, H.; Xie, M.; Qian, J.;
Song, J.; Zhu, X.; Zhang, C. Polydopamine-coated nucleic acid nanogel for siRNA-mediated
low-temperature photothermal therapy. Biomaterials 2020, 245, 119976.
Before 2020
6. Pan, G.; Mou, Q.; Ma, Y.; Ding, F.; Zhang, J.; Guo, Y.; Huang,
X.; Li, Q.; Zhu, X.; Zhang, C. pH-Responsive and Gemcitabine-Containing DNA Nanogel
To Facilitate the Chemodrug Delivery. ACS Applied Materials &
Interfaces 2019, 11, (44), 41082-41090.
5. Ding, F.; Huang, X.; Gao, X.; Xie, M.; Pan, G.; Li, Q.;
Song, J.; Zhu, X.; Zhang, C. A non-cationic nucleic acid nanogel for the delivery of the
CRISPR/Cas9 gene editing tool. Nanoscale 2019, 11, (37), 17211-17215.
4. Huang, X.; Leroux, J.-C.; Castagner, B. Well-Defined
Multivalent Ligands for Hepatocytes Targeting via Asialoglycoprotein Receptor.
Bioconjug. Chem. 2017, 28, (2), 283-295.
3. Huang, X.; Andina, D.; Ge, J.; Labarre, A.; Leroux, J.-C.;
Castagner, B. Characterization of Calcium Phosphate Nanoparticles Based on a PEGylated Chelator
for Gene Delivery. ACS Applied Materials & Interfaces 2017, 9, (12),
10435-10445.
2. Huang, X.; Jiang, X.; Yang, Q.; Chu, Y.; Zhang, G.; Yang,
B.; Zhuo, R. Triple-stimuli (pH/thermo/reduction) sensitive copolymers for intracellular drug
delivery. Journal of Materials Chemistry B 2013, 1, (13), 1860-1868.
1. Huang, X.; Jiang, X.; Zhuo, R. Microwave-assisted
solid-phase synthesis of pH-responsive polyaspartamide derivatives. Carbohydrate
Polymers 2012, 89, (3), 788-794.
